The Role of Nutraceuticals in Statin Intolerant Patients.
(2018) Journal of the american college of cardiology : JACC — Vol. 72, n° 1, p. 96-118 (2018)
Files
2018_Banach_JACC.pdf
Open Access - Adobe PDF
- 693.42 KB
Details
- Authors
- Abstract
- Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non-lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.
- Affiliations
Citations
Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., von Haehling, S., Katsiki, N., Langlois, M., Latkovskis, G., Mancini, G. B. J., Mikhailidis, D. P., Mitchenko, O., Moriarty, P. M., et al. (2018). The Role of Nutraceuticals in Statin Intolerant Patients. Journal of the american college of cardiology : JACC, 72(1), 96-118. https://doi.org/10.1016/j.jacc.2018.04.040 (Original work published 2018)